Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Han

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Archives of Pharmacal Research|June 1, 1997
Changes of nitric oxide synthase activity and free methylarginines contents in regenerating rat liver after partial hepatectomyY J Lee, S W Nam, D W Seo, et al.
Archives of Pharmacal Research|September 18, 1999
Inducible nitric oxide synthase inhibitors from Melia azedarach var. japonicaH C Kwon, B G Lee, S H Kim, et al.
Biochemical Pharmacology|March 29, 2001
Suppression by a sesquiterpene lactone from Carpesium divaricatum of inducible nitric oxide synthase by inhibiting nuclear factor-kappaB activationE J Kim, H K Jin, Y K Kim, et al.
Archives of Pharmacal Research|December 30, 1998
NO/cGMP pathway is involved in exocrine secretion from rat pancreatic acinar cellsS H Ahn, D W Seo, Y K Ko, et al.
Biochemical Pharmacology|June 8, 2001
Enzymatic activation of autotaxin by divalent cations without EF-hand loop region involvementJ Lee, I D Jung, S W Nam, et al.
Oncogene|January 18, 2012
The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasionK J Jeong, S Y Park, K H Cho, et al.
Oncogene|March 31, 2019
Correction: The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasionK J Jeong, S Y Park, K H Cho, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 8, 2007
Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, placebo-controlled trial in 176 Korean subjectsS Kang, K H Kim, Y T Kim, et al.
Oncogene|November 25, 2010
Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expressionS Y Park, K J Jeong, N Panupinthu, et al.
Cancer Research|November 21, 2000
Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolinJ W Han, S H Ahn, S H Park, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Archives of Pharmacal Research|June 1, 1997
Changes of nitric oxide synthase activity and free methylarginines contents in regenerating rat liver after partial hepatectomyY J Lee, S W Nam, D W Seo, et al.
Archives of Pharmacal Research|September 18, 1999
Inducible nitric oxide synthase inhibitors from Melia azedarach var. japonicaH C Kwon, B G Lee, S H Kim, et al.
Biochemical Pharmacology|March 29, 2001
Suppression by a sesquiterpene lactone from Carpesium divaricatum of inducible nitric oxide synthase by inhibiting nuclear factor-kappaB activationE J Kim, H K Jin, Y K Kim, et al.
Archives of Pharmacal Research|December 30, 1998
NO/cGMP pathway is involved in exocrine secretion from rat pancreatic acinar cellsS H Ahn, D W Seo, Y K Ko, et al.
Biochemical Pharmacology|June 8, 2001
Enzymatic activation of autotaxin by divalent cations without EF-hand loop region involvementJ Lee, I D Jung, S W Nam, et al.
Oncogene|January 18, 2012
The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasionK J Jeong, S Y Park, K H Cho, et al.
Oncogene|March 31, 2019
Correction: The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasionK J Jeong, S Y Park, K H Cho, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 8, 2007
Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: a randomized, placebo-controlled trial in 176 Korean subjectsS Kang, K H Kim, Y T Kim, et al.
Oncogene|November 25, 2010
Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expressionS Y Park, K J Jeong, N Panupinthu, et al.
Cancer Research|November 21, 2000
Apicidin, a histone deacetylase inhibitor, inhibits proliferation of tumor cells via induction of p21WAF1/Cip1 and gelsolinJ W Han, S H Ahn, S H Park, et al.
Pageof 9